| Literature DB >> 26546751 |
Quanyin Hu1, Wujin Sun1, Chao Wang1, Zhen Gu2.
Abstract
Combination chemotherapy is widely exploited for enhanced cancer treatment in the clinic. However, the traditional cocktail administration of combination regimens often suffers from varying pharmacokinetics among different drugs. The emergence of nanotechnology offers an unparalleled opportunity for developing advanced combination drug delivery strategies with the ability to encapsulate various drugs simultaneously and unify the pharmacokinetics of each drug. This review surveys the most recent advances in combination delivery of multiple small molecule chemotherapeutics using nanocarriers. The mechanisms underlying combination chemotherapy, including the synergistic, additive and potentiation effects, are also discussed with typical examples. We further highlight the sequential and site-specific co-delivery strategies, which provide new guidelines for development of programmable combination drug delivery systems. Clinical outlook and challenges are also discussed in the end.Entities:
Keywords: Cancer; Chemotherapy; Combination; Drug delivery; Nanocarriers
Mesh:
Year: 2015 PMID: 26546751 PMCID: PMC4998845 DOI: 10.1016/j.addr.2015.10.022
Source DB: PubMed Journal: Adv Drug Deliv Rev ISSN: 0169-409X Impact factor: 15.470